Diabetes: a potential mediator of associations between polycyclic aromatic hydrocarbon exposure and stroke
Authors:
- 9 February 2024
- journal article
- research article
- Published by Springer Nature in Environmental Science and Pollution Research
- p. 1-11
Abstract
Epidemiological evidence suggests associations between exposure to polycyclic aromatic hydrocarbons (PAHs) and cardiovascular diseases (CVD), while diabetes is a common risk factor for CVD. The present study aims to clarify the effect of high PAH exposure on diabetes and stroke in general population. A total of 7849 individuals aged 20 years or older from the National Health and Nutrition Examination Survey 2007–2016 were included in the study. The logistic regression analysis modeled the association between PAH exposure and diabetes as well as stroke. The analysis yielded odds ratios (ORs) and 95% confidence intervals (CIs). The study also evaluated the potential mediating role of diabetes in the relation between PAH exposure and stroke via mediating effect analyses. Of the 7849 eligible participants, 1424 cases of diabetes and 243 cases of stroke were recorded. After adjusting for covariates including age, gender, smoking status, drinking status, education level, marital status, physical activity, hypertension, low-density lipoprotein cholesterol, and BMI, the ORs for stroke in the highest quartile (Q4) of total urinary PAHs were 1.97 (95% CI 1.11–3.52, P = 0.022) as compared to the lowest quartile (Q1) of total urinary PAHs. The ORs for diabetes in the Q4 of total urinary PAHs were 1.56 (95% CI 1.15–2.12, P = 0.005), while the ORs between Q4 and Q1 for stroke and diabetes concerning exposure to 2-hydroxynaphthalene were 2.23 (95% CI 1.17–4.25, P = 0.016) and 1.40 (95% CI 1.07–1.82, P = 0.015), respectively. The mediation analysis found that diabetes accounted for 5.00% of the associations between urinary PAHs and the prevalence of stroke. Urinary metabolites of PAH have been linked to stroke and diabetes. Increasing the risk of diabetes may play a significant role in mediating the association between exposure to PAHs and increased risk of stroke. Monitoring and improving glucose metabolism in individuals with high exposure to PAHs may aid in reducing the prevalence of stroke.Keywords
All Related Versions
Funding Information
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2022-I2M-C&T-B-047)
This publication has 41 references indexed in Scilit:
- Pioglitazone after Ischemic Stroke or Transient Ischemic AttackNew England Journal of Medicine, 2016
- Dose-response relationship between polycyclic aromatic hydrocarbon metabolites and risk of diabetes in the general Chinese populationEnvironmental Pollution, 2014
- Thermochemical properties and phase behavior of halogenated polycyclic aromatic hydrocarbonsEnvironmental Toxicology and Chemistry, 2011
- A Prospective Natural-History Study of Coronary AtherosclerosisNew England Journal of Medicine, 2011
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studiesThe Lancet, 2010
- Multi‐rule quality control for the age‐related eye disease studyStatistics in Medicine, 2008
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet, 2007
- The effects of polycyclic aromatic hydrocarbons on the immune system of fish: A reviewAquatic Toxicology, 2006
- Performance of the Cockcroft-Gault and Modification of Diet in Renal Disease Equations in Estimating GFR in Ill Hospitalized PatientsAmerican Journal of Kidney Diseases, 2005
- Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levelsJACC, 1996